Does Curcumin Mood Meta-Analysis work?

Updated June 2026

Quick Answer

Curcumin Mood Meta-Analysis has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Discussion Overall, Zingiberaceae-derived interventions may improve memory-related outcomes, but the evidence is very uncertain due to substantial heterogeneity, the small number of studies, risk of bias in some trials, and variability in populations, formulations, and outcome measures.

Key Takeaways

  • 01Discussion Overall, Zingiberaceae-derived interventions may improve memory-related outcomes, but the evidence is very uncertain due to substantial heterogeneity, the small number of studies, risk of bias in some trials, and variability in populations, formulations, and outcome measures. [Victoria-Montesinos D (2026)]
  • 02Introduction Cognitive impairment and age-related cognitive decline are major public health concerns, and nutraceutical strategies targeting modifiable biological pathways have attracted growing interest. [Victoria-Montesinos D (2026)]
  • 03Compounds derived from the Zingiberaceae family, including curcumin, turmeric, ginger, and related preparations, have been investigated for their potential neuroprotective effects, but their clinical impact on specific cognitive domains remains unclear. [Victoria-Montesinos D (2026)]
  • 041 2 Depression is a leading cause of disability worldwide and is characterised by sustained low mood, anhedonia, anergia, and a range of associated cognitive and somatic symptoms []. [Muacevic Alexander (2026)]
The current Migaku evidence database contains 2 reusable source documents for Curcumin Mood Meta-Analysis. This answer focuses on strength of evidence and what the studies can or cannot prove. - Discussion Overall, Zingiberaceae-derived interventions may improve memory-related outcomes, but the evidence is very uncertain due to substantial heterogeneity, the small number of studies, risk of bias in some trials, and variability in populations, formulations, and outcome measures. [Victoria-Montesinos D (2026); evidence level 1] - Introduction Cognitive impairment and age-related cognitive decline are major public health concerns, and nutraceutical strategies targeting modifiable biological pathways have attracted growing interest. [Victoria-Montesinos D (2026); evidence level 1] - Compounds derived from the Zingiberaceae family, including curcumin, turmeric, ginger, and related preparations, have been investigated for their potential neuroprotective effects, but their clinical impact on specific cognitive domains remains unclear. [Victoria-Montesinos D (2026); evidence level 1] - 1 2 Depression is a leading cause of disability worldwide and is characterised by sustained low mood, anhedonia, anergia, and a range of associated cognitive and somatic symptoms []. [Muacevic Alexander (2026); evidence level 4] - This literature review summarises key randomised controlled trials (RCTs), meta-analyses, safety data, dosing patterns, and guideline positioning for saffron in depressive disorders, with emphasis on adult major depressive disorder (MDD) and related depressive symptomatology. [Muacevic Alexander (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Effects of Zingiberaceae-derived interventions on memory-related and other cognitive outcomes in adults: a systematic review and meta-analysis.
  2. The Role of Saffron in the Treatment of Depression: A Literature Review